Morgan Stanley Raises Oracle Price Target to $210
Morgan Stanley analyst Sanjit Singh raised the price target on Oracle (NYSE: ORCL) to $210 (from $207) while maintaining a Equalweight rating.
“Remain EW, $210 PT (from $207).
While our EPS estimates move higher on account of improved GPUaaS gross margin trajectory discussed above, we are slightly increasing our PT to $210 (from $207 previously) using ~19x CY28e NGAAP EPS of $10.98.
This implies a ~0.9x PEG (CY26-CY28 CAGR), a discount to ORCL’s historical average of ~1.6x given execution risk and lack of FCF support through forecast period given GPUaaS investment.
Our revised PT compares to our prior base case of $207, which reflected 25x FY28e NGAAP EPS of $8.28.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
